Key facts
- This page summarizes Kaufman 2012 Descendants Trust, David N. Smith, Trustee's Form 4 filing for AGILYSYS INC (AGYS).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 24 Jan 2025, 16:41.
Kaufman 2012 Descendants Trust, David N. Smith, Trustee - 22 Jan 2025 Form 4 Insider Report for AGILYSYS INC (AGYS)
- Reporting relationship
- Affiliate of Director
- Issuer ticker
- AGYS
- Reported as of
- 22 Jan 2025
- Net transaction value
- -$2,192,500
- SEC form
- 4
- Accepted by SEC
- 24 Jan 2025, 16:41:25 UTC
- Prior SEC filing
- 21 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- s/ David N. Smith, As Trustee of the Kaufman 2012 Descendants Trust
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kaufman 2012 Descendants Trust, David N. Smith, Trustee filed Form 4 for AGILYSYS INC (AGYS) on 24 Jan 2025.
Change
- Previous filing in this sequence was filed on 21 Jan 2025.
- Current net transaction value: -$2,192,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AGYS
transaction
Common Stock
Sale
- Transaction value
- $751,275
- Shares
- -7,500
- Change %
- -3%
- Price
- $100.17
- Shares after
- 240,576
- Date
- 22 Jan 2025
- Ownership
- Direct
- Footnotes
- F1, F2
AGYS
transaction
Common Stock
Sale
- Transaction value
- $725,100
- Shares
- -7,500
- Change %
- -3.1%
- Price
- $96.68
- Shares after
- 233,076
- Date
- 23 Jan 2025
- Ownership
- Direct
- Footnotes
- F1, F2
AGYS
transaction
Common Stock
Sale
- Transaction value
- $716,125
- Shares
- -7,692
- Change %
- -3.3%
- Price
- $93.10
- Shares after
- 225,384
- Date
- 24 Jan 2025
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 2 footnotes
Footnote F1
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 Transaction Plan dated September 10, 2024 between the Kaufman Descendants Trust (the "Trust") and Fidelity Brokerage Services LLC. The beneficiaries of the Trust are dependents of Michael Kaufman, who is a director of the Issuer. Michael Kaufman does not have trading authority over the Trust and disclaims beneficial ownership of the shares held by the Trust. The Rule 10b5-1 Trading Plan was completed on January 24, 2025 and there will be no further sales of shares under the Rule 10b5-1 Trading Plan.
Footnote F2
In addition, Michael Kaufman (a) directly beneficially owns 9,580 shares of common stock of the issuer and (b) may be deemed to indirectly beneficially own 1,192,730 shares of common stock of the issuer held by MAK Capital Fund LP ("MAK Fund") by virtue of being the managing director of MAK Capital One LLC which is the investment manager of MAK Fund. Mr. Kaufman has disclaimed such beneficial ownership, except to the extent of its pecuniary interest therein.
SEC remarks
*The reported price is a weighted average. The Reporting Persons undertake to provide to the Issuer and the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.